Rela Institute Of Liver Disease And Transplantation Private Limited - Company Profile

It is a healthcare private limited company based in Chennai, Tamil Nadu, India, established in 2018.
2018 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Rela Institute Of Liver Disease And Transplantation Private Limited

Rela Institute Of Liver Disease And Transplantation Private Limited, a active private limited company, was established on 19 September 2018 in Chennai, Tamil Nadu, India. Engaging in hospitals within the hospital and medical care sector, it holds CIN: U85320TN2018PTC124653. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Shamsudin Mohamed Rela (Managing Director), Thahira Rela (Director), Ramesh Krishnan (Director). Past directors included Shamsudin Mohamed Rela, Mettu Srinivas Reddy, Ramesh Krishnan. Its latest AGM occurred on 27 September 2025, with the balance sheet filed on 31 March 2025. It is based at S.No.73/1, Semmancheri, Old S.No 73/1, Hamlet Of C Kovalam, Thiruvidanthi Vlg, Chennai, Tamil Nadu, 603112.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85320TN2018PTC124653

  • Registration Number

    124653

  • Incorporation Date

    19 September 2018

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 16.31%
  • Profit Growth **** 46.53%
  • Ebitda **** 85.75%
  • Net Worth 52.50%
  • Total Assets -22.48%
Company report

Rela Institute Of Liver Disease And Transplantation Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Rela Institute Of Liver Disease And Transplantation Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rela Institute Of Liver Disease And Transplantation Private Limited?
Current Directors
Name Designation Appointment Date Status
Shamsudin Mohamed Rela Managing Director 19 Sep 2018 Current
Thahira Rela Director 27 Sep 2019 Current
Ramesh Krishnan Director 23 Jan 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 09 Apr 2023 Past
Pramod Abcsdd Director 01 Sep 2023 Past
Pramod Abcsdd Additional Director 27 Sep 2019 Past
Pramod Abcsdd Director 15 May 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rela Institute Of Liver Disease And Transplantation.

Rela Institute Of Liver Disease And Transplantation Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.31% increase. The company also saw a substantial improvement in profitability, with a 46.53% increase in profit. The company's net worth Soared by an impressive increase of 52.5%.

Rela Institute Of Liver Disease And Transplantation revenue growth over time
Rela Institute Of Liver Disease And Transplantation profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 16.31%
*******
*******
*******
*******
Revenue from Operations
*******
 23.56%
*******
*******
*******
*******
Total Assets
*******
 -22.48%
*******
*******
*******
*******
Profit or Loss
*******
 46.53%
*******
*******
*******
*******
Net Worth
*******
 52.50%
*******
*******
*******
*******
EBITDA
*******
 85.75%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rela Institute Of Liver Disease And Transplantation?

In 2021, Rela Institute Of Liver Disease And Transplantation had a public holding of 8.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Rela Institute Of Liver Disease And Transplantation?

Unlock and access historical data on people associated with Rela Institute Of Liver Disease And Transplantation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rela Institute Of Liver Disease And Transplantation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rela Institute Of Liver Disease And Transplantation's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rela Institute Of Liver Disease And Transplantation
Recent Activity within the Organization
  • Annual General Meeting

    Rela Institute Of Liver Disease And Transplantation Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Rela Institute Of Liver Disease And Transplantation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai. was documented.

  • Director Appointment

    The activity Thahira Rela was appointed as a Director was appointed as a Director on 27 Sep 2019 & has been associated with this company since 6 years 5 months . was completed.

  • Director Appointment

    Ramesh Krishnan was appointed as a Director was appointed as a Director on 23 Jan 2019 & has been associated with this company since 7 years 1 month . was recorded as a recent event.

  • Director Appointment

    Shamsudin Mohamed Rela was appointed as a Managing Director was appointed as a Managing Director on 19 Sep 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.

  • Company Incorporation

    The activity Rela Institute Of Liver Disease And Transplantation Private Limited was registered on 19 Sep 2018 with Roc Chennai & aged 7 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Rela Institute Of Liver Disease And Transplantation Private Limited?

The CIN of Rela Institute Of Liver Disease And Transplantation Private Limited is U85320TN2018PTC124653.

Where is Rela Institute Of Liver Disease And Transplantation Private Limited headquartered?

Rela Institute Of Liver Disease And Transplantation Private Limited is headquartered at S.No.73/1, Semmancheri, Old S.No 73/1, Hamlet Of C Kovalam, Thiruvidanthi Vlg, Chennai, Tamil Nadu, 603112.

When was Rela Institute Of Liver Disease And Transplantation Private Limited incorporated?

Rela Institute Of Liver Disease And Transplantation Private Limited was incorporated on 19 September 2018.

Who are the current directors of Rela Institute Of Liver Disease And Transplantation Private Limited?

The current directors of Rela Institute Of Liver Disease And Transplantation Private Limited are

What is the primary industry of Rela Institute Of Liver Disease And Transplantation Private Limited?

The primary industry of Rela Institute Of Liver Disease And Transplantation Private Limited is Hospital And Medical Care.

Is Rela Institute Of Liver Disease And Transplantation Private Limited a listed company?

Rela Institute Of Liver Disease And Transplantation Private Limited is unlisted.

What is the capital structure of Rela Institute Of Liver Disease And Transplantation Private Limited?

The authorized capital of Rela Institute Of Liver Disease And Transplantation Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available